Skip to content
DataLookout
Menu

NCT07901153

Platelet-Rich Plasma, Hyaluronic Acid, or Their Combination for Knee Osteoarthritis in Athletes

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria shortened, about 30 words Show 4 more changesShow less
    • Interventions modified
    • Secondary endpoints: details revised at 2 of 12 entries
    • Study description expanded, about 83 words
    • Site contact updated
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change in WOMAC Total Score From Baseline to 12 Months
Timeframe: Baseline and 12 months after the intervention

Secondary (12)

WOMAC Total and Subscale Scores (Pain, Stiffness and Physical Function)
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Lysholm Knee Scoring Scale
Tegner Activity Level
International Knee Documentation Committee (IKDC) Subjective Knee Form
Show 7 moreShow less
Knee Pain Intensity by Visual Analog Scale (VAS)
Patient Global Impression of Improvement (PGI-I)
Satisfaction With Treatment
Proportion of OMERACT-OARSI Responders
Use of Rescue Medication
Cointerventions, New Injections and Knee Surgery
Incidence of Adverse Events

Arms and interventions

PRP + Hyaluronic AcidExperimental

Single session: ultrasound-guided intra-articular injection of approximately 5 mL of leukocyte-poor PRP (at least 1,000,000 platelets/uL and at least 5 billion platelets), followed in the same session by a single dose of high molecular weight hyaluronic acid.

PRP AloneActive comparator

Single session: ultrasound-guided intra-articular injection of approximately 5 mL of leukocyte-poor PRP (at least 1,000,000 platelets/uL and at least 5 billion platelets).

Hyaluronic Acid AloneActive comparator

Single session: ultrasound-guided intra-articular injection of a single dose of high molecular weight hyaluronic acid. Blood is also collected to preserve participant blinding.

Biologicals: Leukocyte-Poor Platelet-Rich Plasma

Devices: High Molecular Weight Hyaluronic Acid

Sites

1 site in 1 country

  • Institute of Orthopaedics and Traumatology, Hospital das Clinicas, University of Sao Paulo School of Medicine (IOT-HCFMUSP)São Paulo, São Paulo, Brazil